Importer of Controlled Substances Application: Irvine Labs, Inc., 84625 [2024-24553]
Download as PDF
<![CDATA[
Federal Register / Vol. 89, No. 205 / Wednesday, October 23, 2024 / Notices
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.34(a), this
is notice that on August 26, 2024, Irvine
Labs, Inc., 7305 Murdy Circle,
Huntington Beach, California 92647–
3533, applied to be registered as an
importer of the following basic class(es)
of controlled substance(s):
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2024–24560 Filed 10–22–24; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Controlled substance
Drug Enforcement Administration
[Docket No. DEA–1439]
Importer of Controlled Substances
Application: Irvine Labs, Inc.
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Irvine Labs, Inc. has applied
to be registered as an importer of basic
class(es) of controlled substance(s).
Refer to SUPPLEMENTARY INFORMATION
listed below for further drug
information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants, therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before November 22, 2024. Such
persons may also file a written request
for a hearing on the application on or
before November 22, 2024.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment. All
requests for a hearing must be sent to:
(1) Drug Enforcement Administration,
Attn: Hearing Clerk/OALJ, 8701
Morrissette Drive, Springfield, Virginia
22152; and (2) Drug Enforcement
Administration, Attn: DEAFederal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing should
also be sent to: Drug Enforcement
khammond on DSKJM1Z7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
18:48 Oct 22, 2024
Jkt 265001
Lysergic acid
diethylamide.
Marihuana Extract ..........
Marihuana .......................
Tetrahydrocannabinols ...
Mescaline .......................
Peyote ............................
Diethyltryptamine ............
Dimethyltryptamine .........
Psilocybin .......................
Psilocyn ..........................
Drug
code
Schedule
7315
I
7350
7360
7370
7381
7415
7434
7435
7437
7438
I
I
I
I
I
I
I
I
I
The company plans to import bulk
substances to support internal research,
clinical trials, analytical purposes, and
distribution to their customers. In
reference to drug codes Marihuana
Extract (7350), Marihuana (7360) and
Tetrahydrocannabinols (7370) the
company plans to import a raw plant
material and extracts. No other activities
for these drug codes are authorized for
this registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2024–24553 Filed 10–22–24; 8:45 am]
BILLING CODE 4410–09–P
Notice of Lodging of Proposed
Consent Decree Under the Clean Air
Act
On October 17, 2024, the Department
of Justice lodged a proposed consent
decree with the United States District
Court for the District of New Mexico in
the lawsuit entitled United States of
America and New Mexico Environment
Department v. Hilcorp Energy Company,
Civil Action No. 1:24-cv-01055.
In this action, the United States, on
behalf of the U.S. Environmental
Protection Agency, and the New Mexico
PO 00000
Frm 00105
Fmt 4703
Sfmt 4703
Environment Department filed a
complaint alleging that Hilcorp Energy
Company (‘‘Defendant’’) violated the
Clean Air Act, the New Mexico Air
Quality Control Act, and the
implementing regulations for 192 well
completions in New Mexico by failing
to comply with applicable well
completion emissions control
requirements, which resulted in excess
emissions of greenhouse gases and
volatile organic compounds. The
complaint seeks an Order enjoining
Defendant from further violating
applicable requirements and requiring
Defendant to remedy, mitigate, and
offset the harm to public health and the
environment caused by the violations
and to pay a civil penalty.
Under the proposed settlement,
Defendant agrees to pay a civil penalty
of $9,400,000 (of which $4,700,000 is to
be paid to the United States and
$4,700,000 is to be paid to the State of
New Mexico).
In addition, the settlement requires
the Defendant to ensure ongoing
compliance with all applicable
regulatory requirements for all of its
future well completions in New Mexico
and hire an independent third party to
verify compliance.
The publication of this notice opens
a period for public comment on the
proposed consent decree. Comments
should be addressed to the Assistant
Attorney General, Environment and
Natural Resources Division, and should
refer to United States and New Mexico
Environment Department v. Hilcorp
Energy Company, D.J. Ref. No. 90–5–2–
1–12445. All comments must be
submitted no later than thirty (30) days
after the publication date of this notice.
Comments may be submitted either by
email or by mail:
To submit
comments:
Send them to:
By email .......
pubcomment-ees.enrd@
usdoj.gov.
Assistant Attorney General,
U.S. DOJ—ENRD, P.O.
Box 7611, Washington, DC
20044–7611.
By mail .........
DEPARTMENT OF JUSTICE
84625
Any comments submitted in writing
may be filed by the United States in
whole or in part on the public court
docket without notice to the commenter.
During the public comment period,
the proposed consent decree may be
examined and downloaded at this
Justice Department website: https://
www.justice.gov/enrd/consent-decrees.
If you require assistance accessing the
proposed consent decree, you may
request assistance by email or by mail
E:\FR\FM\23OCN1.SGM
23OCN1
]]>Agencies
[Federal Register Volume 89, Number 205 (Wednesday, October 23, 2024)]
[Notices]
[Page 84625]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-24553]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1439]
Importer of Controlled Substances Application: Irvine Labs, Inc.
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Irvine Labs, Inc. has applied to be registered as an importer
of basic class(es) of controlled substance(s). Refer to Supplementary
Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants, therefore, may submit electronic comments on or
objections to the issuance of the proposed registration on or before
November 22, 2024. Such persons may also file a written request for a
hearing on the application on or before November 22, 2024.
ADDRESSES: The Drug Enforcement Administration requires that all
comments be submitted electronically through the Federal eRulemaking
Portal, which provides the ability to type short comments directly into
the comment field on the web page or attach a file for lengthier
comments. Please go to https://www.regulations.gov and follow the
online instructions at that site for submitting comments. Upon
submission of your comment, you will receive a Comment Tracking Number.
Please be aware that submitted comments are not instantaneously
available for public view on https://www.regulations.gov. If you have
received a Comment Tracking Number, your comment has been successfully
submitted and there is no need to resubmit the same comment. All
requests for a hearing must be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEAFederal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152. All requests for a hearing should also be
sent to: Drug Enforcement Administration, Attn: Administrator, 8701
Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on August 26, 2024, Irvine Labs, Inc., 7305 Murdy
Circle, Huntington Beach, California 92647-3533, applied to be
registered as an importer of the following basic class(es) of
controlled substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Lysergic acid diethylamide............. 7315 I
Marihuana Extract...................... 7350 I
Marihuana.............................. 7360 I
Tetrahydrocannabinols.................. 7370 I
Mescaline.............................. 7381 I
Peyote................................. 7415 I
Diethyltryptamine...................... 7434 I
Dimethyltryptamine..................... 7435 I
Psilocybin............................. 7437 I
Psilocyn............................... 7438 I
------------------------------------------------------------------------
The company plans to import bulk substances to support internal
research, clinical trials, analytical purposes, and distribution to
their customers. In reference to drug codes Marihuana Extract (7350),
Marihuana (7360) and Tetrahydrocannabinols (7370) the company plans to
import a raw plant material and extracts. No other activities for these
drug codes are authorized for this registration.
Approval of permit applications will occur only when the
registrant's business activity is consistent with what is authorized
under 21 U.S.C. 952(a)(2). Authorization will not extend to the import
of Food and Drug Administration-approved or non-approved finished
dosage forms for commercial sale.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2024-24553 Filed 10-22-24; 8:45 am]
BILLING CODE 4410-09-P
